Optimal electrode position for transvenous defibrillation: a prospective randomized study

J Am Coll Cardiol. 1996 Jan;27(1):90-4. doi: 10.1016/0735-1097(95)00380-0.

Abstract

Objectives: This study was performed to determine the optimal position for the proximal electrode in a two-electrode transvenous defibrillation system.

Background: Minimizing the energy required to defibrillate the heart has several potential advantages. Despite the increased use of two-electrode transvenous defibrillation systems, the optimal position for the proximal electrode has not been systematically evaluated.

Methods: Defibrillation thresholds were determined twice in random sequence in 16 patients undergoing implantation of a two-lead transvenous defibrillation system; once with the proximal electrode at the right atrial-superior vena cava junction (superior vena cava position) and once with the proximal electrode in the left subclavian-innominate vein (innominate vein position).

Results: The mean (+/- SD) defibrillation threshold with the proximal electrode in the innominate vein position was significantly lower than with the electrode in the superior vena cava position (13.4 +/- 5.7 J vs. 16.3 +/- 6.6 J, p = 0.04). Defibrillation threshold with the proximal electrode in the innominate vein position was lower or equal to that achieved in the superior vena cava position in 75% of patients. In patients with normal heart size (cardiothoracic ratio < or = 0.55), the improvement in defibrillation threshold with the proximal electrode in the innominate vein position was more significant than in patients with an enlarged heart (innominate vein 13.0 +/- 6.5 J vs. superior vena cava 17.9 +/- 5.1 J, p < 0.01). In patients with an enlarged heart, no difference between the two sites was observed (innominate vein 13.9 +/- 4.5 J vs. superior vena cava 13.6 +/- 8.3 J, p = NS).

Conclusions: During implantation of a two-lead transvenous defibrillation system, positioning the proximal defibrillation electrode in the subclavian-innominate vein will lower defibrillation energy requirements in the majority of patients.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Brachiocephalic Veins
  • Defibrillators, Implantable*
  • Electric Countershock / methods*
  • Electrodes, Implanted*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Tachycardia, Ventricular / therapy*
  • Vena Cava, Superior
  • Ventricular Fibrillation / therapy*